v3.25.4
Equity Method Investments (Tables)
12 Months Ended
Dec. 31, 2025
Equity Method Investments [Abstract]  
Schedule of Summary Balance Sheet Information Adovate’s summary balance sheet information as of September 30, 2025 and 2025 is below:

 

   2025   2024 
Current Assets $3,320,934  $1,676,591 
Non-current assets $3,435,768  $3,506,713 
Current liabilities $396,899  $537,303 
Non-current liabilities $6,910,884  $929,156 
Schedule of Adovate’s Operations

Results for Adovate’s operations in the twelve months ended September 30, 2025 and 2024 are summarized below:

 

   2025   2024 
Revenues $  $ 
Costs and expenses  (4,198,259)  (3,248,659)
Loss from operations  (4,198,259)  (3,248,659)
Other income (expenses)  (406,720)  119,886 
Net loss $(4,604,979) $(3,128,773)
Schedule of Equity Method Investment

Activity recorded for the Company’s equity method investment in Adovate in the year ended December 31, 2025 is summarized in the following table:

 

Equity investment carrying amount at January 1, 2024 $1,534,013 
Portion of operating losses recognized  (479,636)
Reduction in equity  (283,268)
Share of dilution to new investors  210,721 
Equity investment carrying amount at December 31, 2024 $981,830 
Portion of operating losses recognized  (492,130)
Equity investment carrying amount at December 31, 2025  489,700